Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 241 of the 242 references it cites were found in a registry or an index.

Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress

Open access
Wu, Xiaomo, Jiang, Ju, Gu, Zhongkai, Zhang, Jinyan, Chen, Yang, Liu, Xiaolong · 2020 · Stem Cell Research & Therapy

Abstract

Mesenchymal stromal cells (MSCs) are a subset of heterogeneous non-hematopoietic fibroblast-like cells that can differentiate into cells of multiple lineages, such as chondrocytes, osteoblasts, adipocytes, myoblasts, and others. These multipotent MSCs can be found in nearly all tissues but mostly located in perivascular niches, playing a significant role in tissue repair and regeneration. Additionally, MSCs interact with immune cells both in innate and adaptive immune systems, modulating immune responses and enabling immunosuppression and tolerance induction. Understanding the biology of MSCs and their roles in clinical treatment is crucial for developing MSC-based cellular therapy for a variety of pathological conditions. Here, we review the progress in the study on the mechanisms underlying the immunomodulatory and regenerative effects of MSCs; update the medical translation of MSCs, focusing on the registration trials leading to regulatory approvals; and discuss how to improve therapeutic efficacy and safety of MSC applications for future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13287-020-01855-9

Cites

241 of 241 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Timeline for major events in studies of the immunosuppressive effects of MSCs and the progress in clinical applications
Fig. 1 Timeline for major events in studies of the immunosuppressive effects of MSCs and the progress in clinical applicationsCC BY · PubMed Central
Fig. 2 Mechanisms mediating immunomodulation. MSCs exert their effect on innate and adaptive immune systems via cell-to-cell interactions and immunomodulatory/regenerative factors. Depleting any one of these molecules would not induce a complete loss of its involved regulatory activities of MSCs and their relative contribution to the therapeutic effects varies between different studies. MSC-mediated immunomodulation and regenerative action is a redundant system, and none of these molecules has an exclusive role
Fig. 2 Mechanisms mediating immunomodulation. MSCs exert their effect on innate and adaptive immune systems via cell-to-cell interactions and immunomodulatory/regenerative factors. Depleting any one of these molecules would not induce a complete loss of its involved regulatory activities of MSCs and their relative contribution to the therapeutic effects varies between different studies. MSC-mediated immunomodulation and regenerative action is a redundant system, and none of these molecules has an exclusive roleCC BY · PubMed Central
Fig. 3 Overview of the molecular mechanisms facilitating each step of MSCs homing
Fig. 3 Overview of the molecular mechanisms facilitating each step of MSCs homingCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 242 references

Research works printed but not linked: 2

  1. Klyushnenkova E, Mosca JD, McIntosh KR, Thiede MA. Human mesenchymal stem cells suppress allogeneic T cell responses in vitro: implications for allogeneic transplantation [abstract]. Blood. 1998;92:642a.
  2. Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD. Manifestations of systemic lupus erythematosus. Maedica. 2011;6:330–6.

Cited by

See all 364

Metadata

Authors
Wu, X., Jiang, J., Gu, Z., Zhang, J., Chen, Y., & Liu, X.
Affiliations
  • University of Basel (CH)
  • Fuzhou Dermatosis Prevention Hospital (CN)
  • Fudan University (CN)
  • Fujian Medical University (CN)
Corresponding author
  • Chen, Yang
  • Liu, Xiaolong
Venue
Stem Cell Research & Therapy
Published
2020-08-08
Volume
11
Issue
1
Pages
345-345
ISSN
1757-6512 (ISSN-L)
OpenAlex
W3047744932
Cited by
343
References
242
Citations by year
2026: 41 · 2025: 70 · 2024: 72 · 2023: 59 · 2022: 55 · 2021: 41 · 2020: 5
FWCI
5.88
Type
journal article
Language
en
Open access
Licence
Locations
  • Stem Cell Research & Therapy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • the science foundation of Fuzhou (2019-S-95)
  • the Key Clinical Specialty Discipline Construction Program of Fuzhou (201807111)
  • the Clinical Medicine Center Construction Program of Fuzhou (2018080309)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Keywords
mesenchymal stem cells, immunomodulation, immunosuppression, tolerance induction, tissue regeneration, multipotency, perivascular niche, clinical translation, regulatory approval, clinical trials, treatment safety
MeSH terms
Cell Differentiation, Immunity, Mesenchymal Stem Cell Transplantation, Immunomodulation, Mesenchymal Stem Cells, Cell- and Tissue-Based Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress. https://app.cochat.ai/papers/10.1186/s13287-020-01855-9
The paper
Wu, X., Jiang, J., Gu, Z., Zhang, J., Chen, Y., & Liu, X. (2020). Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress. Stem Cell Research & Therapy. https://doi.org/10.1186/s13287-020-01855-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.